Lack of neointimal proliferation after implantation of sirolimus-coated stents in human coronary arteries: a quantitative coronary angiography and three-dimensional intravascular ultrasound study.
about
Neointimal expression of rapamycin receptor FK506-binding protein FKBP12: postinjury animal and human in-stent restenosis tissue characteristicsDebate: PCI or CABG for multivessel disease? Viewpoint: No clear winner in an unfair fightDebate: PCI vs CABG: a moving target, but we are gainingPower Approaches for Implantable Medical Devices.Intracoronary brachytherapyClinical update on the therapeutic use of clopidogrel: treatment of acute ST-segment elevation myocardial infarction (STEMI)Effects of local cytochalasin D delivery on smooth muscle cell migration and on collar-induced intimal hyperplasia in the rabbit carotid arteryOral rapamycin attenuates inflammation and enhances stability of atherosclerotic plaques in rabbits independent of serum lipid levels.Fabrication of micropored elastomeric film-covered stents and acute-phase performances.Sirolimus inhibits key events of restenosis in vitro/ex vivo: evaluation of the clinical relevance of the data by SI/MPL- and SI/DES-ratiosLong-term stability of a coronary stent coating post-implantation.Minimally invasive revascularization strategies for chronic lower limb ischemia.c-Jun regulates shear- and injury-inducible Egr-1 expression, vein graft stenosis after autologous end-to-side transplantation in rabbits, and intimal hyperplasia in human saphenous veins.The Integrity bare-metal stent made by continuous sinusoid technology.Long-term follow-up results in patients undergoing percutaneous coronary intervention (PCI) with drug-eluting stents: results from a single high-volume PCI centreDrug-eluting stentsPeripheral arterial disease: clinical assessment and indications for revascularization in the patient with diabetes.Restenosis following coronary angioplasty: current statusGene therapy for coronary restenosis: is the enthusiasm justified?Stent development and local drug delivery.Sirolimus: a comprehensive review.Stent-based antirestenotic coatings (sirolimus/paclitaxel).An evidence-based approach to the use of rotational and directional coronary atherectomy in the era of drug-eluting stents: when does it make sense?Diffuse in-stent restenosis.Potential emerging therapeutic strategies to prevent restenosis in the peripheral vasculature.Coronary artery stents: evaluating new designs for contemporary percutaneous intervention.Cardiovascular toxicities of immunosuppressive agents.New catheter-based technology for the treatment of restenosis.Initial experience with paclitaxel-coated stents.Drug eluting stents: are human and animal studies comparable?Impact of transport and drug properties on the local pharmacology of drug-eluting stents.Biodegradable stents as a platform to drug loading.Drug-eluting stents for cardiovascular disorders.Targeting the cell cycle machinery for the treatment of cardiovascular disease.The small leucine-rich proteoglycan BGN accumulates in CADASIL and binds to NOTCH3New approaches to preventing restenosis.Coronary stenting versus coronary bypass surgery in patients with multiple vessel disease and significant proximal LAD stenosis: results from the ERACI II studyMethotrexate loaded SAE coated coronary stents reduce neointimal hyperplasia in a porcine coronary modelOne year comparison of costs of coronary surgery versus percutaneous coronary intervention in the stent or surgery trial.Role of oral rapamycin to prevent restenosis in patients with de novo lesions undergoing coronary stenting: results of the Argentina single centre study (ORAR trial).
P2860
Q24298705-F7A3257C-F286-4C85-9615-636761B31C53Q24799198-A15229AE-6E51-478E-B031-93713C3FB2A5Q24799287-7729E3F4-197F-4BEF-93F4-AE3EC6A3A8DAQ28088536-E4434D01-C12B-48E7-A3E7-7B66050DFF36Q28193394-60FEB928-BFA5-479D-9DF3-4105DD65B591Q28219418-055AE7D2-3120-4D25-BEBC-76E317EC79F2Q28361022-56EDE1EC-2FBF-4B5B-AA95-3D0B87DEBE09Q30482901-5398215E-9880-4967-AB6D-107878D478D4Q30874456-75A83FE8-1826-4929-B4EF-ABE994389335Q31112412-31A72773-FFB6-4D4F-AC56-7F8C61D1E5B6Q31117668-657D217C-4DD3-48A5-A7A6-4F10E6B85B58Q33236821-ACBC7BCE-3F44-4417-B075-7EFC2F17D70DQ33662275-D4528B52-4D8A-4135-918D-260C5629E45FQ33889866-52AABBF6-AD73-4E67-94B6-2D9E5E8FEBF8Q34024602-66F11545-CFBD-44F8-A870-8471CE70977CQ34091036-28F1D411-77FD-44F2-A381-FE984C8E7484Q34386834-D8C1AD8D-0CF0-45AE-BAE5-62C0C4E23434Q34395052-F6984CFB-4AFC-42E3-9067-5C7987B4B2A1Q34402291-41D858A6-4FD2-4DF8-BE1F-3AB5D5D0CA6FQ34470332-B1065100-673E-42E8-B710-8A1C8DC913A0Q34515537-77765639-9951-42EE-AC6E-CB60CA376A4FQ34547687-D23A9295-F8D1-4EDC-AAD2-054181FEBF2CQ34599083-5B826FB7-E34F-43B5-B6BA-EE84BD608AEBQ34675116-EEB61D68-C806-40C7-9748-11B028E2C50BQ34733613-E9CA6087-88AE-469E-A379-C3E9C98CFEBDQ34747489-D5F99903-211C-451C-AF61-C4CD066246D7Q34976738-E76E96C5-75EB-4E2C-A127-B2664B0882A5Q35002613-7C55B424-9779-4FD1-9055-D92C90DCCF31Q35022887-A6C68FDF-E997-465C-B0DE-0D0412CB8882Q35044969-0533698B-2CB4-4FA1-90D8-EF734B6E01FEQ35080387-5FB599DE-9A40-4708-A791-9BC4B81D0E41Q35080390-681F9CC1-B102-46F0-B978-20D50913D197Q35148405-CA4F2B8F-21EE-4A49-9E4D-1C00EC01D518Q35164884-492A0EA9-05AB-48E1-96D9-5C12992A3418Q35175576-FF3EF929-7D24-4CCD-AC55-B6F7EE4F9068Q35190937-1840EA12-FB75-4860-A6D9-975914EA1FF6Q35580809-387D624E-D8B8-4478-8FD1-5F7CDB4B4FE0Q35582047-8AA06511-453E-446C-9FD0-FC48B15C445DQ35582564-3081E3E0-1E6F-4455-A06C-7BE58D671D89Q35584915-9A25EFD5-B339-446B-AA79-5AC43209480A
P2860
Lack of neointimal proliferation after implantation of sirolimus-coated stents in human coronary arteries: a quantitative coronary angiography and three-dimensional intravascular ultrasound study.
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Lack of neointimal proliferati ...... ntravascular ultrasound study.
@ast
Lack of neointimal proliferati ...... ntravascular ultrasound study.
@en
type
label
Lack of neointimal proliferati ...... ntravascular ultrasound study.
@ast
Lack of neointimal proliferati ...... ntravascular ultrasound study.
@en
prefLabel
Lack of neointimal proliferati ...... ntravascular ultrasound study.
@ast
Lack of neointimal proliferati ...... ntravascular ultrasound study.
@en
P2093
P356
P1433
P1476
Lack of neointimal proliferati ...... ntravascular ultrasound study.
@en
P2093
Abizaid AS
Falotico R
P304
P356
10.1161/01.CIR.103.2.192
P407
P577
2001-01-01T00:00:00Z